These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30108174)

  • 1. LEM domain-containing protein 3 antagonizes TGFβ-SMAD2/3 signaling in a stiffness-dependent manner in both the nucleus and cytosol.
    Chambers DM; Moretti L; Zhang JJ; Cooper SW; Chambers DM; Santangelo PJ; Barker TH
    J Biol Chem; 2018 Oct; 293(41):15867-15886. PubMed ID: 30108174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
    Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
    Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling.
    Lin F; Morrison JM; Wu W; Worman HJ
    Hum Mol Genet; 2005 Feb; 14(3):437-45. PubMed ID: 15601644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
    Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
    Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway.
    Kato M; Takahashi F; Sato T; Mitsuishi Y; Tajima K; Ihara H; Nurwidya F; Baskoro H; Murakami A; Kobayashi I; Hidayat M; Shimada N; Sasaki S; Mineki R; Fujimura T; Kumasaka T; Niwa SI; Takahashi K
    Drug Des Devel Ther; 2020; 14():4593-4603. PubMed ID: 33149556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.
    Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A
    Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for receptor-regulated SMAD recognition by MAN1.
    Miyazono KI; Ohno Y; Wada H; Ito T; Fukatsu Y; Kurisaki A; Asashima M; Tanokura M
    Nucleic Acids Res; 2018 Dec; 46(22):12139-12153. PubMed ID: 30321401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response.
    Tu AW; Luo K
    J Biol Chem; 2007 Jul; 282(29):21187-96. PubMed ID: 17478422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling.
    Wrighton KH; Willis D; Long J; Liu F; Lin X; Feng XH
    J Biol Chem; 2006 Dec; 281(50):38365-75. PubMed ID: 17035229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt1 interaction with active Smad2 modulates transforming growth factor-β regulated transcription.
    García-Vizcaíno EM; Liarte S; Alonso-Romero JL; Nicolás FJ
    Cell Commun Signal; 2017 Nov; 15(1):50. PubMed ID: 29187201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-beta signaling.
    Dai F; Lin X; Chang C; Feng XH
    Dev Cell; 2009 Mar; 16(3):345-57. PubMed ID: 19289081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
    van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
    Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.
    Lin X; Duan X; Liang YY; Su Y; Wrighton KH; Long J; Hu M; Davis CM; Wang J; Brunicardi FC; Shi Y; Chen YG; Meng A; Feng XH
    Cell; 2006 Jun; 125(5):915-28. PubMed ID: 16751101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids regulate TGFbeta signaling at the level of Smad2 phosphorylation and nuclear accumulation.
    Hoover LL; Burton EG; O'Neill ML; Brooks BA; Sreedharan S; Dawson NA; Kubalak SW
    Biochim Biophys Acta; 2008 Dec; 1783(12):2279-86. PubMed ID: 18773928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway.
    Bu S; Kapanadze B; Hsu T; Trojanowska M
    J Biol Chem; 2008 Jul; 283(28):19593-602. PubMed ID: 18482992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
    Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
    J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
    Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
    Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain.
    Dai F; Chang C; Lin X; Dai P; Mei L; Feng XH
    Mol Cell Biol; 2007 Sep; 27(17):6183-94. PubMed ID: 17591701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.